Down with the Erythropoietin. Long Live the Erythropoietin !

E-ISSN： 1873-5592|10|10|1028-1032

ISSN： 1389-4501

Source： Current Drug Targets, Vol.10, Iss.10, 2009-10, pp. : 1028-1032

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Erythropoietin: From Hematopoiesis to Cardioprotection

By Meer Peter Lipsic Erik Gilst Wiek Veldhuisen Dirk

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 1, 2005-01 ,pp. : 7-8

Springer Publishing Company

Access to resources Recommend Favorite

A neuroprotective derivative of erythropoietin that is not erythropoietic

By Doggrell Sheila A

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. : 1517-1519

Informa Healthcare

Access to resources Recommend Favorite

Cancer Patient Survival and Erythropoietin

By Glaspy John A.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 3, Iss. 6, 2005-11 ,pp. : 796-804

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Effects of Erythropoietin on Brain Function

Current Pharmaceutical Biotechnology, Vol. 6, Iss. 1, 2005-02 ,pp. : 65-79

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Basis of Cardioprotection by Erythropoietin

Current Molecular Pharmacology, Vol. 2, Iss. 1, 2009-01 ,pp. : 56-69

Bentham Science Publishers

Access to resources Recommend Favorite